Organicell Regenerative Medicine, Inc. Debenture Agreements
1 Contracts & Agreements
- Form of 2018 6% Convertible Debenture Issued by Biotech Products Services And Research, Inc., a Nevada corporation (Filed With SEC on November 1, 2018)
